- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00428753
China Case Control Avian Influenza
May 29, 2008 updated by: National Institute of Allergy and Infectious Diseases (NIAID)
Matched Case-Control Study of Risk Factors for Human Infection With Avian Influenza A (H5N1) Virus, China
This study will determine risk factors of human infection with avian influenza A virus, also known as bird flu virus.
Certain risk factors such as exposure to poultry, travel history, health status, and other factors may affect one's risk of getting bird flu.
Study participants will include individuals, older than age 1, that tested positive for influenza A (H5N1) in a previous surveillance program and controls (individuals that have not tested positive for avian influenza A (H5N1) and have no fever or respiratory symptoms).
There will be 1 study visit during which volunteers will be asked detailed questions about their health, work, and travel habits.
Study participants will be asked to donate a blood sample to test for antibodies, the part of the blood that fights infection.
Study Overview
Status
Completed
Conditions
Detailed Description
This study is a matched case-control study of risk factors for human infection with avian influenza A (H5N1) virus in China.
The primary study objective is to determine the risk factors for avian influenza A (H5N1) virus infection in humans, in China, whether or not the subject was symptomatic.
The confirmed case-patients and confirmed antibody positive avian influenza A (H5N1) persons (asymptomatic or sub-clinical) identified by the previously done National Surveillance Program will be included in this study as cases.
Controls will be identified from population registries in villages with rural cases and in the adjacent apartment buildings of the urban cases' residences.
If the National Surveillance Program identifies healthcare workers infected with avian influenza A (H5N1) virus, healthcare workers in the same department of the healthcare facilities in which the cases worked will also be included as controls.
A matched case-control study will be conducted with a ratio of 4 controls per 1 case.
Cases and controls who meet the eligibility criteria will be consented and enrolled in the study.
After enrollment a questionnaire will be administered to obtain information on demographic characteristics, underlying diseases, daily activities, shopping habits, poultry raising in the backyard, poultry vaccination, exposure to sick/dead poultry or healthy appearing poultry, visits to places where live poultry were kept (e.g., poultry stalls, retail markets, wholesale markets or poultry farms) in the week before illness, eating habits, food preparation activities related to poultry, children's activities such as playing with poultry and swimming in water with water fowl, exposure to other animals including wild birds, and exposure to other humans with respiratory illnesses or confirmed H5N1 case-patients.
Survived cases, individuals whose specimen H5N1 tested positive in previous National Surveillance Program and controls will be asked to provide a blood sample to determine whether they have antibodies to H5N1.
New confirmed cases and controls will be asked to donate a blood sample for H5N1 antibody testing.
Any control that tests positive will become a case and additional controls will be identified.
All samples will be tested for H5N1 antibodies with hemagglutination inhibition (using horse red blood cells) and microneutralization assay.
If all negative, the individual will be considered sero-negative; if all positive, the individual will be considered sero-positive for the purposes of this study; if results from hemagglutination inhibition (HI) and microneutralization (MN) assays are discordant, the MN result will be considered the final result (negative or positive).
Appropriate antigens for the assays will be selected based on the antigenic characteristics of the virus circulating in the region at the time of sample collection.
HI and MN assays will be performed according to accepted SOPs.
The study will be completed within one year.
Study Type
Observational
Enrollment
100
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Bejing, China, 100050
- Chinese Center for Disease Control and Prevention
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 year and older (Child, Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
Participants should be informed and assent to participate in this study. For children, informed consent should be provided by their parents or legal guardians. Children aged from 10 years old to 18 years old will be asked to assent.
- Adults or children older than 1 year old.
- Satisfying above definition of cases and controls
Exclusion Criteria:
- Infants younger than 12 months
For any cases or controls who need proxy, they should be excluded under below situations:
- Proxy can not provide sufficient information for this study, or
- Proxy refuses to participate in this study, or
- No suitable proxy can be found.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2007
Study Completion
January 1, 2008
Study Registration Dates
First Submitted
January 25, 2007
First Submitted That Met QC Criteria
January 26, 2007
First Posted (Estimate)
January 30, 2007
Study Record Updates
Last Update Posted (Estimate)
May 30, 2008
Last Update Submitted That Met QC Criteria
May 29, 2008
Last Verified
May 1, 2008
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 06-0070
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.